Our companies have generated personalized drug factories in the body, developed therapeutics to attack the root cause of Alzheimer’s, and created performance-grade leather (without the cow).

Our companies have generated personalized drug factories in the body, developed therapeutics to attack the root cause of Alzheimer’s, and created performance-grade leather (without the cow).

Portfolio

Checkerspot

Synthetic biology and chemistry to produce novel bio-derived oils from microalgae

Cortexyme

(Nasdaq; CRTX) Therapeutics to alter the course of Alzheimer’s and other aging disorders

Cytovale

Clinical diagnostics to measure biophysical markers of single cells

Immusoft

Genetically modifying B cells to create sustained protein-producing therapeutics in the body

Modern Meadow

Biologically advanced sustainable new materials

Opus 12

Transforming industrial carbon dioxide emissions into useful chemicals

Phylagen

Indoor microbiome data analytics for human health and supply chain tracking

ShiraTronics

Novel neuromodulation technologies to combat debilitating migraine headaches

Strateos

Automating chemical, biological and image analysis to accelerate drug discovery

Team

The team at Breakout is building a future powered by science and spent the last decade commercializing opportunities at the intersection of biology, chemistry and technology.

Breakout Ventures invests at Seed, Series A and Series B. 

Lindy Fishburne

Managing Partner

Julia Moore

Managing Partner

Dana Watt

Principal

Hemai Parthasarathy

Board Partner

Renee Shenton

Community Manager

Breakout Labs

50 Seed Stage Companies

Learn More

Breakout Labs
50 Seed Stage Companies

Learn more
Contact Us
LP Portal